Advanced search
Publication Cover
Leukemia & Lymphoma Volume 28, 1998 - Issue 3-4
Submit an article Journal homepage
20
Views
0
CrossRef citations to date
0
Altmetric
Original Article

A Phase I Trial of High Dose ProMace-CytaBOM with Granulocyte Colony Stimulating Factor for Patients with Non-Hodgkin's Lymphoma

Thomas E. Witzig From the Division of Internal Medicine and Hematology Mayo Clinic and Mayo Foundation, Rochester, MN, 55905Correspondence[email protected]
,
John K. Camoriano Division of Hematology/Oncology, Mayo Clinic, Scottsdale, AZ, USA
,
Georgene Schroeder Cancer Center Statistics Unit (GS), Mayo Clinic and Mayo Foundation, Rochester, MN, 55905
,
Paul J. Kurtin Department of Laboratory Medicine Mayo Clinic and Mayo Foundation, Rochester, MN, 55905
&
Thomas M. Habermann From the Division of Internal Medicine and Hematology Mayo Clinic and Mayo Foundation, Rochester, MN, 55905
Pages 307-314 | Received 25 May 1997, Published online: 01 Jul 2009

References

  • McKelvey E., Gottlieb J., Wilson H., Haut A., Talley R., Stephens R., Lane M., Gamble J., Jones S., Grozea P., Gutterman J., Coltman C., Jr., Moon T. Hydroxyldaunomycin (Adriamycin) combination chemotherapy in malignant lymphoma. Cancer 1976; 38: 1484–1493
  • Connors J., Klimo P. MACOP-B chemotherapy for malignant lymphomas and related conditions: 1987 update and additional observations. Seminars in Hematology 1988; 25: 41–46
  • Dana B., Dahlberg S., Miller T., Hartsock R., Balcerzak S., Coltman C., Carden J., Hartley K., Fisher R. m-BACOD treatment for intermediate and high-grade malignant lymphomas: A Southwest Oncology Group phase II trial. Journal of Clinical Oncology 1990; 8: 1155–1162
  • Longo D., DeVita V., Jr., Duffey P., Wesley M., Ihde D., Hubbard S., Gilliom M., Jaffe E., Cossman J., Fisher R., Young R. Superiority of ProMACE-CytaBOM over ProMACE-MOPP in the treatment of advanced diffuse aggressive lymphoma: results of a prospective randomized trial. Journal of Clinical Oncology 1991; 9: 25–38
  • Skarin A., Canellos G., Rosenthal D., Case D., Jr., Maclntyre J., Pinkus G., Moloney W., Frei E., III. Improved prognosis of diffuse histiocytic and undifferentiated lymphoma by use of high-dose methotrexate alternating with standard agents (M-BACOD). Journal of Clinical Oncology 1983; 1: 91–98
  • Fisher R., Gaynor E., Dahlberg S., Oken M., Grogan T., Mize E., Glick J., Coltman C., Jr., Miller T. Comparison of a standard regimen (Chop) with three intensive regimens for advanced non-Hodgkin's lymphoma. New England Journal of Medicine 1993; 328: 1002–1006
  • Gaynor E., Fisher R. Chemotherapy of intermediate-grade non-Hodgkin's lymphoma: is “more” or “less” better?. Oncology 1995; 9: 1273–1279
  • Gordon L., Andersen J., Habermann T., Winter J., Glick J., Schilder R., Cassileth P. Phase I trial of dose escalation with growth factor support in patients with previously untreated diffuse aggressive lymphomas: determination of the maximum-tolerated dose of ProMACE-CytaBOM. Journal of Clinical Oncology 1996; 14: 1275–1281
  • Shipp M., Neuberg D., Janicek M., Canellos G., Shulman L. High-dose Chop as initial therapy for patients with poor-prognosis aggressive non-Hodgkin's lymphoma: a dose-finding pilot study. Journal of Clinical Oncology 1995; 13: 2916–2923

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.